Prescription Drugs

Prescription Drug Materials

• Biden-Harris Administration Acts to Lower Prices for 27 Drugs

  March 21, 2023: On Wednesday, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced 27 prescription drugs for which Medicare Part B beneficiary coinsurances may be lower from Read More >

• New Retiree Voting Record Report Released

  March 13, 2023:  Scores Congress on Votes Including the Landmark “Inflation Reduction Act” Washington, DC – The Alliance for Retired Americans released its 2022 Congressional Voting Record, which scored each U.S. Senator and Representat Read More >

• Insulin Prices Cut for More Patients as Eli Lilly Caves to Pressure

  March 07, 2023: Drug corporation Eli Lilly announced Wednesday that it will cap out-of-pocket patient costs for its two most popular insulin drugs, Humalog and Humulin, at $35 a month. Patients with private insurance and who use participating pha Read More >

• Battle Over ‘Orphan Drugs’ Leads to Higher Drug Prices

  February 27, 2023: An “orphan drug” is a designation that rewards drug corporations for developing treatments for rare diseases. When a drugmaker wins approval for an orphan drug, the company is entitled to seven years of exclusive rights to the Read More >

• Drug Corporations Plan Price Increases on Life-Saving Medications Despite Billions in Increased Profits

  January 30, 2023: Major pharmaceutical corporations are set to increase prices on over 350 unique medications this month, continuing a trend of drug industry profiteering, according to Accountable.US and Reuters. A previous Accountable.US report sh Read More >

• HHS Announces Key Dates for Implementation of Medicare Drug Price Negotiation

  January 17, 2023: The U.S. Department of Health and Human Services (HHS) has announced key 2023 dates for the Medicare Drug Price Negotiation Program which lowers drug costs for millions of Americans. For the first time in history, because of th Read More >

• House Investigation into Alzheimer’s Drug Places Blame on FDA, Biogen

  January 09, 2023: The Food and Drug Administration’s process for approving the Alzheimer’s drug Aduhelm, despite great uncertainty about whether it worked, was “rife with irregularities,” according to a congressional investigation. The repo Read More >

• Kaiser Health News: States Challenge Biden to Lower Drug Prices by Allowing Imports From Canada

  December 21, 2022: The Biden administration is facing mounting pressure from states to let them import medicine from Canada to help lower prescription drug costs. Colorado on Dec. 5 became at least the fourth state to seek federal permission to u Read More >

• Kaiser Health News: Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.

  December 09, 2022: Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with covid-19 from being hospitalized or dying, and it may even reduce the ris Read More >

• Seniors Laud President Biden’s Executive Order Further Lowering Drug Costs

  October 14, 2022: The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding the Executive Order directing the Department of Health and Human Services to explore additional actions it c Read More >